Monocusp valve in right ventricular outflow tract

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Biomedical Engineering

Background:

• Congenital heart disease necessitates complex surgical interventions.
• Right ventricular outflow tract reconstruction is a critical component of corrective surgery.
• Pulmonary regurgitation remains a significant challenge in these procedures.

Purpose of the Study:

• To evaluate the efficacy and durability of monocusp valve implants in pediatric patients undergoing right ventricular outflow tract reconstruction.
• To assess the incidence of pulmonary regurgitation and valve failure following monocusp valve implantation.
• To determine the long-term outcomes and need for reoperation in patients receiving monocusp valves.

Main Methods:

• A cohort of sixty pediatric patients (aged 5 days-10.3 years) received monocusp valve implants.
• The monocusp valve was surgically attached to the posterior wall of the pulmonary tract.
• Follow-up duration ranged from 0 to 11.5 years, with a mean of 3.8 years.

Main Results:

• Early and late mortality rates were 8.3% and 3.6%, respectively.
• All patients developed monocusp valve regurgitation post-implantation.
• Moderate or severe valve failure occurred in 30 patients, necessitating repeat surgery in seven cases.

Conclusions:

• Monocusp valves provide a potential short-term solution for reducing pulmonary regurgitation in right ventricular outflow tract reconstruction.
• The high incidence of regurgitation and valve failure suggests that long-term outcomes may require further investigation and potentially repeat surgical interventions.
• Long-term follow-up is crucial to ascertain the ultimate necessity of reoperation for all patients with monocusp valves.